Abstract
To the Editor: We read with interest the article by Dr Ortolani and coworkers1 on the results of their study of 2-year clinical outcome of drug-eluting stents for diabetic patients. They concluded that the use of drug-eluting stents was associated with a modest reduction in the 2-year risk of target vessel revascularization compared with the use of bare-metal stents. In their study, a significant reduction in risk of major adverse cardiac events by drug-eluting stent implantation was identified in non-insulin-dependent diabetic …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
